Literature DB >> 8784581

Amplification of rRNA for assessment of treatment response of pulmonary tuberculosis patients during antimicrobial therapy.

D F Moore1, J I Curry, C A Knott, V Jonas.   

Abstract

The time course of persistence of Mycobacterium tuberculosis as measured by detection of rRNA, acid-fast bacillus (AFB) smear, and culture was determined for pulmonary tuberculosis patients during antimicrobial therapy. Twenty-three patients who were initially AFB smear positive and who subsequently completed a course of antimicrobial therapy were selected for the study. Sequential specimens were tested by AFB smear, culture, and rRNA amplification (Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test [MTD]). The initial diagnostic specimens of all patients were positive by culture; those of 22 patients (96%) also were positive by MTD. Overall, MTD results remained positive longer than both smear and culture results. The median times to the last positive test result were 9 days for AFB smear, 26 days for culture, and 30 days for MTD. The last positive test result was the AFB smear result in 4% of cases, the culture result in 22%, and the MTD result in 52%. Fifty-six percent of patients had a period of shedding of noncultivable M. tuberculosis which was detected by MTD after culture results had converted to negative. This noncultivable period lasted 7 to 245 days. All three tests became reproducibly negative before the end of therapy and remained negative during follow-up for up to 1 year. These results indicate that during successful antimicrobial therapy, M. tuberculosis is eliminated in sputum samples as measured by amplification of rRNA, as well as by AFB smear and culture. No long-term rRNA carrier state was detected. While the time course of clearance of M. tuberculosis measured by rRNA overall was longer than with the two traditional tests, the rRNA test results allow sensitive and precise measurement of the clearance of noncultivable M. tuberculosis from respiratory specimens. This attribute may allow rRNA testing to be useful in clarifying patient response to antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784581      PMCID: PMC229106     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Identification of mycobacteria by high-performance liquid chromatography.

Authors:  W R Butler; K C Jost; J O Kilburn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

2.  Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction.

Authors:  P W Hermans; A R Schuitema; D Van Soolingen; C P Verstynen; E M Bik; J E Thole; A H Kolk; J D van Embden
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Quantitative studies of mycobacterial populations in sputum and saliva.

Authors:  H Yeager; J Lacy; L R Smith; C A LeMaistre
Journal:  Am Rev Respir Dis       Date:  1967-06

4.  Nonculturable acid-fast forms in the sputum of patients with tuberculosis and chronic pulmonary disease.

Authors:  F C Warring; U Sutramongkole
Journal:  Am Rev Respir Dis       Date:  1970-11

5.  Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment.

Authors:  T C Kim; R S Blackman; K M Heatwole; T Kim; D F Rochester
Journal:  Am Rev Respir Dis       Date:  1984-02

6.  Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis.

Authors:  K Y Yuen; K S Chan; C M Chan; B S Ho; L K Dai; P Y Chau; M H Ng
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

7.  Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection.

Authors:  K A Workowski; M F Lampe; K G Wong; M B Watts; W E Stamm
Journal:  JAMA       Date:  1993-11-03       Impact factor: 56.272

8.  Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA.

Authors:  V Jonas; M J Alden; J I Curry; K Kamisango; C A Knott; R Lankford; J M Wolfe; D F Moore
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Direct detection of Mycobacterium tuberculosis in respiratory specimens in a clinical laboratory by polymerase chain reaction.

Authors:  B A Forbes; K E Hicks
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

10.  Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory.

Authors:  J E Clarridge; R M Shawar; T M Shinnick; B B Plikaytis
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

View more
  18 in total

1.  Evaluation of three nucleic acid amplification methods for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Authors:  S X Wang; L Tay
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Evaluation of a commercial ligase chain reaction kit (Abbott LCx) for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens.

Authors:  E Tortoli; F Lavinia; M T Simonetti
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Rapid detection of Mycobacterium tuberculosis in respiratory samples by transcription-reverse transcription concerted reaction with an automated system.

Authors:  Shunji Takakura; Shigeo Tsuchiya; Yuichi Isawa; Kiyoshi Yasukawa; Toshinori Hayashi; Motohisa Tomita; Katsuhiro Suzuki; Tatsuro Hasegawa; Takanori Tagami; Atsuyuki Kurashima; Satoshi Ichiyama
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Performance characteristics and utilization of rapid antigen test, DNA probe, and culture for detection of group a streptococci in an acute care clinic.

Authors:  Kimberle C Chapin; Patricia Blake; Claire D Wilson
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Mycobacterium growth indicator tube testing in conjunction with the AccuProbe or the AMPLICOR-PCR assay for detecting and identifying mycobacteria from sputum samples.

Authors:  S Ichiyama; Y Iinuma; S Yamori; Y Hasegawa; K Shimokata; N Nakashima
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplification of mRNA.

Authors:  T J Hellyer; L E DesJardin; L Teixeira; M D Perkins; M D Cave; K D Eisenach
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis.

Authors:  T J Hellyer; L E DesJardin; G L Hehman; M D Cave; K D Eisenach
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

8.  Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy.

Authors:  L Li; C S Mahan; M Palaci; L Horter; L Loeffelholz; J L Johnson; R Dietze; S M Debanne; M L Joloba; A Okwera; W H Boom; K D Eisenach
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

9.  False-positive Gen-Probe direct Mycobacterium tuberculosis amplification test results for patients with pulmonary M. kansasii and M. avium infections.

Authors:  J H Jorgensen; J R Salinas; R Paxson; K Magnon; J E Patterson; T F Patterson
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Performance characteristics of the BDProbeTec system for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Authors:  G E Pfyffer; P Funke-Kissling; E Rundler; R Weber
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.